PL3202421T3 - Emulsje o/w zawierające semifluorowane alkany - Google Patents
Emulsje o/w zawierające semifluorowane alkanyInfo
- Publication number
- PL3202421T3 PL3202421T3 PL17159788T PL17159788T PL3202421T3 PL 3202421 T3 PL3202421 T3 PL 3202421T3 PL 17159788 T PL17159788 T PL 17159788T PL 17159788 T PL17159788 T PL 17159788T PL 3202421 T3 PL3202421 T3 PL 3202421T3
- Authority
- PL
- Poland
- Prior art keywords
- emulsions
- semifluorinated alkanes
- semifluorinated
- alkanes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11150064 | 2011-01-04 | ||
EP17159788.3A EP3202421B1 (en) | 2011-01-04 | 2012-01-03 | O/w-emulsions comprising semifluorinated alkanes |
EP12700455.4A EP2661280B1 (en) | 2011-01-04 | 2012-01-03 | O/w-emulsions comprising semifluorinated alkanes |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3202421T3 true PL3202421T3 (pl) | 2018-10-31 |
Family
ID=43978091
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL17159788T PL3202421T3 (pl) | 2011-01-04 | 2012-01-03 | Emulsje o/w zawierające semifluorowane alkany |
PL12700455T PL2661280T3 (pl) | 2011-01-04 | 2012-01-03 | Emulsje typu olej w wodzie zawierające semifluorowane alkany |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12700455T PL2661280T3 (pl) | 2011-01-04 | 2012-01-03 | Emulsje typu olej w wodzie zawierające semifluorowane alkany |
Country Status (15)
Country | Link |
---|---|
US (5) | US20140004197A1 (pl) |
EP (2) | EP3202421B1 (pl) |
JP (1) | JP6073244B2 (pl) |
KR (1) | KR101910213B1 (pl) |
CN (1) | CN103313729B (pl) |
AU (1) | AU2012204932B2 (pl) |
BR (1) | BR112013016661B1 (pl) |
CA (1) | CA2819988C (pl) |
DK (2) | DK2661280T3 (pl) |
ES (2) | ES2675242T3 (pl) |
MX (1) | MX353154B (pl) |
PL (2) | PL3202421T3 (pl) |
PT (2) | PT3202421T (pl) |
TR (2) | TR201808752T4 (pl) |
WO (1) | WO2012093113A1 (pl) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2547323B1 (en) | 2010-03-17 | 2016-01-27 | Novaliq GmbH | Pharmaceutical composition for treatment of increased intraocular pressure |
EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
EP2714008B1 (en) | 2011-05-25 | 2016-12-14 | Novaliq GmbH | Pharmaceutical composition for administration to nails |
CA2834855C (en) | 2011-05-25 | 2020-12-29 | Novaliq Gmbh | Topical pharmaceutical composition based on semifluorinated alkanes |
DK2806886T3 (en) | 2012-01-23 | 2017-06-06 | Novaliq Gmbh | STABILIZED PROTEIN COMPOSITIONS BASED ON SEMIFLUORED ALKANES |
AU2013314303B2 (en) | 2012-09-12 | 2018-01-18 | Novaliq Gmbh | Semifluorinated alkane compositions |
MX363182B (es) | 2012-09-12 | 2019-03-13 | Novaliq Gmbh | Composiciones que comprenden mezclas de alcanos semifluorados. |
GB2511028A (en) * | 2012-12-18 | 2014-08-27 | Univ Manchester Metropolitan | Nano emulsions, methods of forming the same and uses thereof |
EP2783703A1 (en) * | 2013-03-25 | 2014-10-01 | B. Braun Melsungen AG | Semifluorocarbon compound containing contrast agent |
JP6503349B2 (ja) | 2013-07-23 | 2019-04-17 | ノバリック ゲーエムベーハー | 安定化された抗体組成物 |
KR20160145558A (ko) | 2014-03-03 | 2016-12-20 | 앙코르 비전, 인코포레이티드 | 리포산 콜린 에스테르 조성물 및 사용 방법 |
EP3495023B1 (en) | 2015-09-30 | 2020-04-22 | Novaliq GmbH | Semifluorinated compounds and their compositions |
US11154513B2 (en) | 2015-09-30 | 2021-10-26 | Novaliq Gmbh | Semifluorinated compounds |
WO2017220625A1 (en) | 2016-06-23 | 2017-12-28 | Novaliq Gmbh | Topical administration method |
EP3515420B1 (en) | 2016-09-22 | 2023-11-08 | Novaliq GmbH | Pharmaceutical compositions for use in the therapy of blepharitis |
KR20190057338A (ko) | 2016-09-23 | 2019-05-28 | 노바리크 게엠베하 | 시클로스포린을 포함하는 안과 조성물 |
AU2018253944B2 (en) | 2017-04-21 | 2022-09-15 | Dermaliq Therapeutics, Inc. | Iodine compositions |
EP3619186B1 (en) | 2017-05-05 | 2021-02-17 | Novaliq GmbH | Process for the production of semifluorinated alkanes |
EP3621601A1 (en) | 2017-05-12 | 2020-03-18 | Novaliq GmbH | Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions |
US11723861B2 (en) | 2017-09-27 | 2023-08-15 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
US11896559B2 (en) | 2017-10-04 | 2024-02-13 | Novaliq Gmbh | Opthalmic compositions comprising F6H8 |
WO2019166631A1 (en) | 2018-03-02 | 2019-09-06 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
CA3111870C (en) | 2018-09-27 | 2022-04-12 | Novaliq Gmbh | Topical sunscreen formulation |
ES2974839T3 (es) | 2018-10-12 | 2024-07-01 | Novaliq Gmbh | Composición oftálmica para el tratamiento de la enfermedad de ojos secos |
US11547714B2 (en) | 2020-02-05 | 2023-01-10 | Epalex Corporation | Fospropofol salts, methods and compositions |
US11439653B1 (en) | 2021-03-30 | 2022-09-13 | Epalex Corporation | Fospropofol formulations |
US11628178B2 (en) | 2019-03-26 | 2023-04-18 | Epalex Corporation | Fospropofol methods and compositions |
US11478490B1 (en) | 2021-03-30 | 2022-10-25 | Epalex Corporation | Fospropofol formulations |
EP3912621A1 (en) * | 2020-05-19 | 2021-11-24 | tesa Labtec GmbH | Propofol for diagnosis of primary headache |
FR3112475B1 (fr) | 2020-07-20 | 2023-11-10 | Naos Inst Of Life Science | formulation écobiologique, compatible avec la vie cellulaire, utilisable dans les domaines cosmétiques, dermopharmaceutiques ou vétérinaires |
WO2022169520A1 (en) * | 2021-02-05 | 2022-08-11 | Epalex Corporation | Fospropofol methods and compositions |
DE102021005495A1 (de) | 2021-11-06 | 2023-05-11 | Kocher-Plastik Maschinenbau Gmbh | Trennvorrichtung |
DE102021005494A1 (de) | 2021-11-06 | 2023-05-11 | Kocher-Plastik Maschinenbau Gmbh | Trennvorrichtung |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5077036A (en) * | 1986-01-14 | 1991-12-31 | Alliance Pharmaceutical Corp. | Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid |
FR2679150A1 (fr) * | 1991-07-17 | 1993-01-22 | Atta | Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations. |
DE19536504C2 (de) * | 1995-09-29 | 1999-09-23 | H Meinert | Verwendung fluorierter Alkane |
DE19709704C2 (de) * | 1997-03-10 | 1999-11-04 | Michael Georgieff | Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie |
DE69912441T2 (de) * | 1998-08-19 | 2004-08-19 | Skyepharma Canada Inc., Verdun | Injizierbare wässerige propofoldispersionen |
US6140374A (en) | 1998-10-23 | 2000-10-31 | Abbott Laboratories | Propofol composition |
WO2000054588A1 (en) | 1999-03-15 | 2000-09-21 | John Claude Krusz | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
US6177477B1 (en) * | 1999-03-24 | 2001-01-23 | American Home Products Corporation | Propofol formulation containing TRIS |
US6399087B1 (en) * | 2000-12-20 | 2002-06-04 | Amphastar Pharmaceuticals, Inc. | Propofol formulation with enhanced microbial inhibition |
CA2446060A1 (en) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
JP2007511616A (ja) * | 2003-11-19 | 2007-05-10 | バーンズ−ジューイッシュ ホスピタル | 増強された薬物送達 |
DE602006004887D1 (de) | 2005-08-05 | 2009-03-05 | Bharat Serums & Vaccines Ltd | Intravenöse propofol-emulsionszusammensetzungen mit konservierendem effekt |
TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
ES2377152T3 (es) | 2008-04-18 | 2012-03-22 | Novaliq Gmbh | Uso inhalativo e instilativo de alcanos semifluorados como vehículos de principios activos en la región intrapulmonar |
-
2012
- 2012-01-03 TR TR2018/08752T patent/TR201808752T4/tr unknown
- 2012-01-03 DK DK12700455.4T patent/DK2661280T3/en active
- 2012-01-03 PT PT171597883T patent/PT3202421T/pt unknown
- 2012-01-03 EP EP17159788.3A patent/EP3202421B1/en active Active
- 2012-01-03 ES ES17159788.3T patent/ES2675242T3/es active Active
- 2012-01-03 US US13/978,334 patent/US20140004197A1/en not_active Abandoned
- 2012-01-03 WO PCT/EP2012/050043 patent/WO2012093113A1/en active Application Filing
- 2012-01-03 AU AU2012204932A patent/AU2012204932B2/en active Active
- 2012-01-03 CA CA2819988A patent/CA2819988C/en active Active
- 2012-01-03 EP EP12700455.4A patent/EP2661280B1/en active Active
- 2012-01-03 ES ES12700455T patent/ES2711760T3/es active Active
- 2012-01-03 PL PL17159788T patent/PL3202421T3/pl unknown
- 2012-01-03 KR KR1020137018703A patent/KR101910213B1/ko active IP Right Grant
- 2012-01-03 CN CN201280004613.1A patent/CN103313729B/zh active Active
- 2012-01-03 DK DK17159788.3T patent/DK3202421T3/en active
- 2012-01-03 PL PL12700455T patent/PL2661280T3/pl unknown
- 2012-01-03 PT PT12700455T patent/PT2661280T/pt unknown
- 2012-01-03 TR TR2019/01309T patent/TR201901309T4/tr unknown
- 2012-01-03 BR BR112013016661-4A patent/BR112013016661B1/pt active IP Right Grant
- 2012-01-03 JP JP2013546732A patent/JP6073244B2/ja not_active Expired - Fee Related
- 2012-01-03 MX MX2013007807A patent/MX353154B/es active IP Right Grant
-
2017
- 2017-04-19 US US15/491,521 patent/US20170216204A1/en not_active Abandoned
-
2019
- 2019-01-28 US US16/259,037 patent/US20190224123A1/en not_active Abandoned
-
2020
- 2020-04-30 US US16/863,918 patent/US20200360285A1/en not_active Abandoned
-
2022
- 2022-12-23 US US18/146,306 patent/US20230139672A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL3202421T3 (pl) | Emulsje o/w zawierające semifluorowane alkany | |
HK1247116A1 (zh) | 基於半氟化烷烴類的外用藥物組合物 | |
AU338052S (en) | Goggles | |
PL2806886T3 (pl) | Stabilizowane kompozycje białkowe oparte na semifluorowanych alkanach | |
ZA201403090B (en) | Tropicalizing agent | |
EP2724729A4 (en) | APOPTOSIS INDUCING AGENT | |
GB201111438D0 (en) | Formulation | |
PL3701800T3 (pl) | Zastosowanie | |
ZA201309221B (en) | Formulation | |
HK1211858A1 (en) | Diclofenac composition | |
GB201121705D0 (en) | Multiple use footwear | |
ZA201402456B (en) | Formulation | |
EP2787050A4 (en) | LECITHIN-Organogel formers | |
TWI562734B (en) | Sense-improving agent | |
EP2687212A4 (en) | DRUG AGENT | |
EP2764870A4 (en) | MEANS FOR IMPROVED SENSUAL ASSESSMENT | |
EP2863894A4 (en) | fenofibrate | |
EP2863890A4 (en) | FORMULATION OF FENOFIBRATE | |
GB201106958D0 (en) | Formulation | |
GB201119383D0 (en) | Rara | |
GB201102289D0 (en) | New use | |
GB2483187B (en) | Goggles | |
GB201104284D0 (en) | Formulation | |
GB201119436D0 (en) | Use | |
PL396249A1 (pl) | Organizer endodontyczny |